| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 3, 2025 | Feb 5, 2025 | Allogene Therapeutics, Inc. | EVP of R&D | Sell | 46.3 | -18,832 | -2.84% | ✗ | $32K |
| Jan 21, 2025 | Jan 23, 2025 | Allogene Therapeutics, Inc. | EVP of R&D | Sell | 46.3 | -27,199 | -5.28% | ✗ | $48.4K |
| Jan 22, 2024 | Jan 24, 2024 | Allogene Therapeutics, Inc. | EVP of R&D | Sell | 42.5 | -24,690 | -6.17% | ✗ | $78.4K |